NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report

BACKGROUND: NUT (nuclear protein in testis) midline carcinoma (NMC) is a rapidly progressive tumor arising from midline structures. Recent cases have reported that the poor prognosis with a median survival of 6.7 months and a 2 years overall survival of 19% due to limited treatment. Based on the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jin, Ren, Yikun, Xu, Chengping, Lin, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742416/
https://www.ncbi.nlm.nih.gov/pubmed/34996489
http://dx.doi.org/10.1186/s13000-021-01188-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742416/
https://www.ncbi.nlm.nih.gov/pubmed/34996489
http://dx.doi.org/10.1186/s13000-021-01188-y

Ejemplares similares